Transient Ischemic Attack — ED Workup and Disposition

Key Points

• Resolved symptoms do not make TIA benign; early stroke risk is highest in the first days.
• If a focal deficit persists, manage as acute ischemic stroke and assess reperfusion eligibility.
• MRI with DWI is preferred for detecting small acute infarction when rapidly available.
• Head and neck vascular imaging is central to identifying high-risk arterial disease.
• Obtain ECG and evaluate for atrial fibrillation and other cardioembolic sources.
• Do not use ABCD2 alone to determine ED discharge.
• Short-course dual antiplatelet therapy is appropriate only for selected high-risk TIA or minor noncardioembolic stroke patients.
• Symptomatic carotid stenosis and recurrent crescendo TIAs require urgent specialist management.

Algorithm

1. Confirm that symptoms were sudden and focal and determine whether any deficit persists.
2. If symptoms persist, activate the acute stroke pathway.
3. Check glucose and obtain urgent brain imaging to exclude hemorrhage and identify infarction.
4. Obtain CTA or MRA of the head and neck to assess carotid, intracranial, and vertebrobasilar disease.
5. Perform ECG and cardiac monitoring; plan prolonged rhythm assessment if embolic source remains unclear.
6. Start antithrombotic therapy appropriate to the mechanism after hemorrhage is excluded.
7. Initiate statin and vascular risk-factor management.
8. Use imaging findings, recurrent symptoms, comorbidity, and access to rapid follow-up to choose admission, observation, or expedited TIA clinic.

Clinical Synopsis & Reasoning

A TIA is defined by tissue rather than by an arbitrary symptom duration: transient focal neurologic dysfunction caused by brain, spinal cord, or retinal ischemia without acute infarction. Symptoms often resolve before evaluation, which makes history the center of diagnosis. Sudden unilateral weakness or numbness, aphasia, dysarthria, hemianopia, monocular vision loss, diplopia with other posterior circulation signs, or abrupt gait and coordination deficits are more concerning for ischemia than isolated nonspecific dizziness, generalized weakness, or confusion.

The differential includes migraine aura, seizure with postictal deficit, hypoglycemia, peripheral vestibular disorders, neuropathy, functional neurologic symptoms, and syncope. Positive spreading sensory phenomena and slowly evolving symptoms favor migraine; stereotyped recurrent positive motor activity suggests seizure. However, no single feature is definitive, and high-risk vascular patients can have atypical presentations.

Early stroke risk after a true TIA is front-loaded, with many events occurring within the first days. The ED goal is therefore not merely to confirm that symptoms resolved. It is to identify acute infarction, symptomatic carotid or intracranial stenosis, atrial fibrillation, dissection, and other high-risk mechanisms that change treatment immediately. MRI with diffusion-weighted imaging is more sensitive than CT for small acute infarcts, while CTA or MRA of the head and neck identifies arterial disease that may require urgent intervention.

ABCD2 and similar scores can summarize clinical risk but should not be used alone to decide discharge. They do not reliably capture high-risk imaging findings, atrial fibrillation, recurrent crescendo events, or the ability to obtain rapid follow-up. A patient with a low numerical score but symptomatic carotid stenosis is not low risk.

Treatment Strategy & Disposition

If the patient still has a disabling focal deficit, treat as an acute ischemic stroke and activate reperfusion evaluation rather than labeling the event a TIA. For resolved symptoms, obtain urgent brain imaging. Noncontrast CT is widely available and excludes hemorrhage or major alternative pathology, but MRI with DWI is preferred when rapidly accessible because it can identify acute infarction and reclassify the event as stroke.

Perform vascular imaging of the cervical and intracranial circulation unless a clearly nonvascular diagnosis is established. CTA is efficient in the ED and can identify severe carotid stenosis, intracranial stenosis, occlusion, or dissection. Obtain ECG and cardiac monitoring for atrial fibrillation; longer outpatient rhythm monitoring is often needed when no cause is found. Laboratory testing includes glucose, CBC, renal function, and lipids or other secondary-prevention studies as appropriate.

Start antiplatelet therapy promptly after hemorrhage has been excluded in patients without an indication for anticoagulation. For selected patients with high-risk TIA or minor noncardioembolic ischemic stroke, short-course dual antiplatelet therapy with aspirin plus clopidogrel started early reduces recurrent stroke risk, but it is not appropriate for every TIA and should follow a stroke protocol that accounts for bleeding risk and mechanism. Atrial fibrillation generally calls for anticoagulation rather than chronic dual antiplatelet therapy, with timing individualized if an infarct is present.

Initiate intensive vascular risk reduction, including high-intensity statin therapy when indicated, blood pressure management, diabetes treatment, and smoking cessation. Symptomatic high-grade carotid stenosis requires urgent vascular or stroke consultation because carotid revascularization can be time-sensitive. Admit when rapid imaging, telemetry, specialist evaluation, or treatment cannot be completed safely as an outpatient. A well-resourced observation or rapid TIA clinic pathway can be appropriate when all critical testing and follow-up are guaranteed within a short interval.

Epidemiology / Risk Factors

• TIA is a common warning event preceding ischemic stroke.
• Risk of stroke is greatest in the hours and days after the event.
• Large-artery atherosclerosis and atrial fibrillation are important high-risk mechanisms.
• A substantial fraction of clinically diagnosed TIAs have acute infarction on MRI and are therefore tissue-defined strokes.
• Vascular risk factors include hypertension, diabetes, smoking, dyslipidemia, age, and prior cardiovascular disease.

Investigations

Disposition Snapshot

Pharmacology

Prognosis / Complications

• Prompt etiologic evaluation and secondary prevention can substantially reduce recurrent stroke risk.
• Symptomatic carotid stenosis, atrial fibrillation, DWI-positive infarction, and recurrent events increase near-term risk.
• Patients with a convincing mimic generally have a different prognosis, but the diagnosis should be secure before de-escalating stroke evaluation.
• Long-term outcome depends on control of blood pressure, lipids, diabetes, tobacco exposure, and the identified stroke mechanism.
• Medication adherence after TIA is critical because the event may be the only warning before a disabling stroke.

Patient Education / Counseling

• Explain that TIA is a stroke warning even though the symptoms disappeared.
• Call emergency services immediately for any recurrent weakness, numbness, speech difficulty, vision loss, severe imbalance, or other focal symptom.
• Review antiplatelet or anticoagulant instructions carefully and emphasize bleeding precautions.
• Discuss smoking cessation, blood pressure control, lipid treatment, diabetes care, diet, and physical activity.
• Provide a precise follow-up pathway with stroke clinic, vascular surgery, cardiology, or rhythm monitoring as indicated.
• Advise against driving if recurrent neurologic symptoms or residual deficits could impair safe operation until cleared.

Notes

The tissue-based definition matters because a patient can have symptoms lasting only minutes and still have a small acute infarct on MRI. That patient has had a stroke, not a TIA, and the finding can influence prognosis and treatment. Conversely, many transient neurologic symptoms are mimics. The diagnostic task is therefore both to identify ischemia and to avoid reflexively labeling every brief symptom as TIA.

Disposition should be judged by what will actually happen next. A rapid TIA clinic with same-day vascular imaging and prompt specialist review may be safer than admission in one system, while discharge with an appointment weeks later is not an equivalent pathway.

References

1. American Heart Association Scientific Statement: TIA in the Emergency Department — Link
2. AHA/ASA Guideline for Prevention of Stroke in Patients With Stroke and TIA — Link